ZA877454B - Therapeutic agent for the treatment of peptic ulcer disease - Google Patents

Therapeutic agent for the treatment of peptic ulcer disease

Info

Publication number
ZA877454B
ZA877454B ZA877454A ZA877454A ZA877454B ZA 877454 B ZA877454 B ZA 877454B ZA 877454 A ZA877454 A ZA 877454A ZA 877454 A ZA877454 A ZA 877454A ZA 877454 B ZA877454 B ZA 877454B
Authority
ZA
South Africa
Prior art keywords
treatment
therapeutic agent
peptic ulcer
ulcer disease
oxohexyl
Prior art date
Application number
ZA877454A
Other languages
English (en)
Inventor
Masao Sakurai
Sakurai Masao
Masayoshi Goto
Goto Masayoshi
Toshizo Tanaka
Tanaka Toshizo
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of ZA877454B publication Critical patent/ZA877454B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA877454A 1986-10-06 1987-10-05 Therapeutic agent for the treatment of peptic ulcer disease ZA877454B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23607886 1986-10-06

Publications (1)

Publication Number Publication Date
ZA877454B true ZA877454B (en) 1988-05-25

Family

ID=16995393

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA877454A ZA877454B (en) 1986-10-06 1987-10-05 Therapeutic agent for the treatment of peptic ulcer disease

Country Status (16)

Country Link
US (1) US4845102A (de)
EP (1) EP0266559B1 (de)
JP (1) JPS63225317A (de)
KR (1) KR950007101B1 (de)
AT (1) ATE75399T1 (de)
AU (1) AU595379B2 (de)
CA (1) CA1297021C (de)
DE (1) DE3778642D1 (de)
DK (1) DK169305B1 (de)
ES (1) ES2032797T3 (de)
GR (1) GR3004848T3 (de)
HU (1) HU200098B (de)
IE (1) IE60863B1 (de)
IL (1) IL84096A (de)
PT (1) PT85866B (de)
ZA (1) ZA877454B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
DE4025371A1 (de) * 1990-08-10 1992-02-13 Kali & Salz Ag Verfahren zur reinigung von elektrostatisch gewonnenem steinsalz
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH608236A5 (de) * 1974-01-22 1978-12-29 Wuelfing J A Fa
CA1075690A (en) * 1974-12-13 1980-04-15 Hoechst Aktiengesellschaft Xanthine derivatives
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
IT1200944B (it) * 1982-08-10 1989-01-27 Malesci Sas Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement

Also Published As

Publication number Publication date
DK520787D0 (da) 1987-10-05
DK169305B1 (da) 1994-10-10
IL84096A0 (en) 1988-03-31
IE60863B1 (en) 1994-08-24
IE872656L (en) 1988-04-06
HU200098B (en) 1990-04-28
AU595379B2 (en) 1990-03-29
ATE75399T1 (de) 1992-05-15
JPS63225317A (ja) 1988-09-20
KR880004810A (ko) 1988-06-27
CA1297021C (en) 1992-03-10
EP0266559A2 (de) 1988-05-11
EP0266559B1 (de) 1992-04-29
EP0266559A3 (en) 1990-06-06
AU7935887A (en) 1988-04-14
PT85866A (en) 1987-11-01
PT85866B (pt) 1990-07-31
ES2032797T3 (es) 1993-03-01
IL84096A (en) 1991-07-18
DK520787A (da) 1988-04-07
HUT46214A (en) 1988-10-28
GR3004848T3 (de) 1993-04-28
KR950007101B1 (ko) 1995-06-30
US4845102A (en) 1989-07-04
DE3778642D1 (de) 1992-06-04

Similar Documents

Publication Publication Date Title
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
ZA877454B (en) Therapeutic agent for the treatment of peptic ulcer disease
PH25188A (en) 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoervthromycin a derivatives, pharmaceutical composition containing said compound and method of use thereof
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DK288787A (da) Kondenserede imidazo-heterocycliske forbindelser, fremgangsmaade til deres fremstilling, og deres anvendelse som laegemidler
DE68921051D1 (de) Pyridin-3-percarboxylsäure monopersulfat.
GR3021569T3 (en) Use of xanthine derivatives against peptic ulcers
GR3004095T3 (de)
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
TW360630B (en) A secoaporphine compounds on arrhythmia
NO870499D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.